131 filings
DEFA14A
GOSS
Gossamer Bio Inc
24 Apr 24
Additional proxy soliciting materials
4:02pm
DEF 14A
GOSS
Gossamer Bio Inc
Definitive proxy
24 Apr 24
4:01pm
8-K
GOSS
Gossamer Bio Inc
12 Mar 24
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan
4:01pm
S-8
GOSS
Gossamer Bio Inc
5 Mar 24
Registration of securities for employees
7:37am
10-K
2023 FY
GOSS
Gossamer Bio Inc
Annual report
5 Mar 24
7:32am
8-K
e2ly6j5
5 Mar 24
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:31am
8-K
vlhfhf9h
4 Mar 24
Other Events
4:02pm
8-K
64wtyu0 azlo1niz6uvw
29 Nov 23
Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors
4:01pm
8-K
4mbq dmyv
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
8-K
49kmi ppluhnn073o2
9 Nov 23
Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
7:31am
8-K
a3q k6yu47hd
20 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
8-K
g6h4ejfu
7 Sep 23
Departure of Directors or Certain Officers
5:00pm
EFFECT
rayy3vf
29 Aug 23
Notice of effectiveness
12:15am
424B3
3949 morwzb
28 Aug 23
Prospectus supplement
4:29pm
UPLOAD
tp69i41obn4wl35y
24 Aug 23
Letter from SEC
12:00am
CORRESP
maz38j
24 Aug 23
Correspondence with SEC
12:00am
S-3
0f5pum y4
18 Aug 23
Shelf registration
8:41am
RW
4ewegsefx04q v3
18 Aug 23
Registration withdrawal request
8:38am
S-3ASR
w4968
17 Aug 23
Automatic shelf registration
4:01pm